Skip to content
Drug recall · FDA · Published April 29, 2021

Lupin Pharmaceuticals Inc. recalls Cefixime for Oral Suspension USP 100 mg/5mL, 50mL HDPE bottles, Rx Only, Manufactured by: Lupin Pharmaceuticals, Inc.

Lupin Pharmaceuticals recalls Cefixime oral suspension 100mg/5mL bottles due to subpotent drug content. This means the medication may not be as effective as labeled. Consumers should contact the manufacturer for details.

🇺🇸 FDA recall #D-0390-2021DrugLupin Pharmaceuticals ›
Take action

Contact the company & request your remedy

Recalling firmLupin Pharmaceuticals Inc.Harborplace Tower, 111 S Calvert St Fl 21st · Baltimore, MD 21202-6174
No email on file for this recall — reach the company by phone or its official page instead.No email on file — write to the address above instead.
✎ GovInfoNow plain-language explainer

What happened, in plain English

Lupin Pharmaceuticals is recalling Cefixime oral suspension bottles that may contain less active ingredient than labeled. This could lead to the medication being less effective than intended, potentially requiring higher doses for the same effect. Read more at govinfonow.com/recall/36165-lupin-cefixime-oral-suspension-recall-subpotent-drug-risk.

Source Summary by GovInfoNow · govinfonow.com/recall/36165-lupin-cefixime-oral-suspension-recall-subpotent-drug-risk · Updated October 4, 2026 · FDA enforcement record: FDA #D-0390-2021

Cite this page

“Lupin Cefixime Oral Suspension Recall: Subpotent Drug Risk.” GovInfoNow, updated October 4, 2026. https://govinfonow.com/recall/36165-lupin-cefixime-oral-suspension-recall-subpotent-drug-risk. Based on FDA recall #D-0390-2021 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0390-2021%22&limit=1).

Why it’s dangerous

The medication may have lower-than-labeled active ingredient levels, meaning it might not work as effectively as intended. This could result in the treatment not being as strong as needed for the patient's condition.

Who’s affected

Prescription holders of Cefixime oral suspension 100mg/5mL, 50mL bottles with NDC 68180-405-01 and lot number F900787 are affected. Patients on this medication are most at risk.

How to tell if you have this one

Check for Cefixime oral suspension bottles labeled 100 mg/5mL, 50mL HDPE, with NDC 68180-405-01 and lot number F900787. The product is prescription-only and manufactured by Lupin Pharmaceuticals.

  • Brand
    Lupin Pharmaceuticals
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Contact Manufacturer

    Reach out to Lupin Pharmaceuticals for specific instructions on handling the recalled product.

✎ GovInfoNow

Questions people ask

Is this product safe to use?

The recall is for subpotent drug content, meaning it may not be as effective as labeled. It is not safe to use without consulting the manufacturer.

What should I do with the recalled product?

Contact Lupin Pharmaceuticals for specific instructions on handling the recalled product.

How can I check if my product is recalled?

Check for the NDC 68180-405-01 and lot number F900787 on the bottle label.

Take action

Contact Lupin Pharmaceuticals

We’ve drafted a message you can send Lupin Pharmaceuticals to request your refund or repair — edit it as you like.

Subject: Recall D-0390-2021 — Lupin Pharmaceuticals Lupin Pharmaceuticals

Hello,

I own a Lupin Pharmaceuticals that is covered by recall D-0390-2021 from Lupin Pharmaceuticals.

I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this?

Thank you.

Similar recalls

Keep exploring

From people who’ve dealt with this

Experiences, tips, and questions from readers. Every comment is reviewed before it appears.

No comments yet — be the first to share your experience.

Comments are reviewed before they appear. No links, ads, or personal attacks — those get removed.

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0390-2021 (April 29, 2021) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0390-2021 to see it in context.
  • Plain-language summary written by qwen3:4b on October 4, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA